filings.toolsItem 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
There have been no material changes to the risk factors disclosed in Item 1A in our 2024 10-K, as updated by the risk factors disclosed in our quarterly report on Form 10-Q for the quarterly period ended March 31, 2025.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Common stock repurchases during the three months ended June 30, 2025:
| Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs | |||||||||||||||||||
| April 1 - April 30, 2025 | 1,059,583 | $ | 75.52 | — | — | ||||||||||||||||||
| May 1 - May 31, 2025 | 122,607 | 76.89 | — | — | |||||||||||||||||||
| June 1 - June 30, 2025 | 736,398 | 73.31 | — | — | |||||||||||||||||||
| 1,918,588 | $ | 74.00 | — | — |
During the three months ended June 30, 2025, we purchased 1,795,981 shares of our common stock for general corporate purposes in the open market, including under a plan meeting the requirements of Rule 10b5-1 under the Exchange Act, and we withheld 122,607 shares from employees to satisfy estimated statutory income tax obligations related to vesting of restricted stock awards and stock option exercises. The value of the common stock withheld was based on the closing price of our common stock on the applicable vesting or exercise date. There were no unregistered sales of equity securities during the three months ended June 30, 2025.
Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 5. Other Information